Table 3.
Oligometastatic disease ≤3 lesions | Widespread disease >4 lesions | |
---|---|---|
PSMA PET/CT, n (%) | 143 (37.2) | 63 (16.4) |
CT and BS, n (%) | 102 (26.6) | 15 (3.9) |
BS, bone scan; CT, computed tomography; PET/CT, positron emission tomography/computed tomography; PSMA, prostate-specific membrane antigen.